Role of the Gut Microbiome in Metabolic Dysfunction-Associated Steatotic Liver Disease
{{output}}
The prevalence of metabolic dysfunction-associated steatotic liver disease (MASLD)-previously described as nonalcoholic fatty liver disease-continues to rise globally. Despite this, therapeutic measures for MASLD remain limited. Recently, there has been a grow... ...
